ID   GZLSL-i001-A
AC   CVCL_A4EK
SY   HA-LSL-iPSC
DR   Wikidata; Q105507507
RX   PubMed=33212352;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Sequence variation: Mutation; HGNC; HGNC:3546; F8; Unexplicit; Inv22 (IVS22 INV); ClinVar=VCV000010150; Zygosity=Hemizygous (PubMed=33212352).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
RX   PubMed=33212352; DOI=10.1016/j.scr.2020.102053;
RA   Lu D., Xue Y.-T., Song B., Liu N.-Q., Xie Y.-J., Cheng Y., Chen B.-Z.,
RA   He L.-N., Chen D.-Y., Zeng J., Yang Y.-H., Guo X.-X., Li Y.-S.,
RA   Sun X.-F.;
RT   "Generation of induced pluripotent stem cell GZLSL-i001-A derived from
RT   urine-derived cells of hemophilia A patient with Inv22 mutation.";
RL   Stem Cell Res. 49:102053-102053(2020).
//